Synairgen is a University spin-off and public limited company (plc) working in drug discovery and biotechnology. It was founded in 2003 by University...
9 KB (841 words) - 00:58, 18 August 2022
PMID 33264556. "COVID Trial at Home - developed by Synairgen". Covid Trial at Home - developed by Synairgen. Archived from the original on 2022-05-07. Retrieved...
32 KB (2,851 words) - 23:22, 16 August 2024
the University of Southampton. In 2003, Davies was the co-founder of Synairgen, an interferon-beta drug designed to treat patients with asthma and chronic...
10 KB (981 words) - 09:02, 7 November 2023
used this patented information to create the University spin-off company Synairgen to explore the potential therapeutic benefits of inhaled interferon beta...
7 KB (629 words) - 13:34, 11 October 2024
clinical trials of a drug developed by Southampton-based biotech firm Synairgen, that uses the protein interferon beta, have shown promising signs. The...
272 KB (32,014 words) - 00:11, 13 September 2024
initiatives[which?] against COVID-19, including the Solidarity trial. UK biotech firm Synairgen started conducting trials on IFN-β, a drug that was originally developed...
128 KB (14,817 words) - 01:34, 9 September 2024